You have 3 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

L-asparaginase resistant

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Lymphoblastic Lymphoma Trial

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • +5 more
  • Biospecimen Collection
  • +4 more
  • (no location specified)
Oct 28, 2022

Lymphoblastic Leukemia in Children Trial (induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal

Not yet recruiting
  • Lymphoblastic Leukemia in Children
  • induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal Methotrexate
  • +7 more
  • (no location specified)
Oct 24, 2023

Acute Lymphoblastic Leukemia Trial in Memphis (Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine
  • Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 26, 2022

NSCLC Trial in Zhengzhou (L-TIL, Tislelizumab, Docetaxel)

Recruiting
  • Non-small Cell Lung Cancer
  • L-TIL, Tislelizumab, Docetaxel
  • Zhengzhou, Henan, China
    No.127 Dongming Road
May 17, 2023

Pancreatic Cancer Trial (GRASPA)

Completed
Has Results
  • Pancreatic Cancer
  • (no location specified)
Sep 20, 2021

Acute Lymphoblastic Leukemia, in Relapse Trial in Belgium, France (GRASPA, L-asparaginase)

Completed
Has Results
  • Acute Lymphoblastic Leukemia, in Relapse
  • Bruxelles, Belgium
  • +27 more
Feb 1, 2022

End Stage Renal Disease, Hypertension, Renal Trial in Alexandria (L-Methyl Folate and methylcobalamine)

Recruiting
  • End Stage Renal Disease
  • Hypertension, Renal
  • L-Methyl Folate and methylcobalamine
  • Alexandria, Egypt
    Faculty of Pharmacy, Alexandria University
Mar 29, 2023

Acute Lymphoblastic Leukemia, Hyperbilirubinemia Trial in Houston (Levocarnitine, Vitamin B Complex)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Hyperbilirubinemia
  • Levocarnitine
  • Vitamin B Complex
  • Houston, Texas
    M D Anderson Cancer Center
Nov 7, 2022

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia

Not yet recruiting
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • +5 more
  • Biospecimen Collection
  • +12 more
  • (no location specified)
Mar 8, 2023

Acute Myeloid Leukemia Trial in France (GRASPA)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Nice, Alpes Maritimes, France
  • +20 more
Feb 18, 2022

Drug/Agent Toxicity by Tissue/Organ, Leukemia Trial in Canada, Puerto Rico, United States (asparaginase, cyclophosphamide,

Completed
Has Results
  • Drug/Agent Toxicity by Tissue/Organ
  • Leukemia
  • Boston, Massachusetts
  • +9 more
Nov 9, 2022

Extranodal NK/T-cell Lymphoma Trial in Bangkok (B-MAD chemo)

Active, not recruiting
  • Extranodal NK/T-cell Lymphoma
  • B-MAD chemotherapy
  • Bangkok, Thailand
    King Chulalongkorn Memorial Hospital
May 7, 2022

Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia

Recruiting
  • Recurrent B Acute Lymphoblastic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2022

Acute B-Cell Lymphoblastic Leukaemia Trial in Brazil (Spectrila®)

Recruiting
  • Acute B-Cell Lymphoblastic Leukaemia
  • Belo Horizonte, Brazil
  • +7 more
Aug 26, 2022

Digestive System Cancers Trial in Beijing (KN046, Regorafenib, Apatinib)

Recruiting
  • Digestive System Cancers
  • Beijing, China
    Peking University Cancer Hospital
Oct 25, 2023

Acute Lymphoblastic Leukemia Trial (GRASPA)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • (no location specified)
Sep 21, 2021

Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Trial in

Not yet recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • +6 more
  • Biopsy
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Apr 26, 2022

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,

Recruiting
  • Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Lymphoma
  • Palo Alto, California
  • +6 more
May 2, 2022

B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Nov 8, 2023

Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type Trial in Shanghai (Anlotinib)

Completed
  • Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
  • Shanghai, China
    Xinhua Hospital
Sep 13, 2021

Leukemia Trial in Portland (cyclophosphamide, cytarabine, dexamethasone)

Terminated
Has Results
  • Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 13, 2022

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Memphis (drug, biological, radiation)

Not yet recruiting
  • Refractory Acute Lymphoblastic Leukemia
  • Relapsed Acute Lymphoblastic Leukemia
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 23, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, PARP Inhibitor Trial in Pittsburgh

Not yet recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +3 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 8, 2022

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Miami (Pevonedistat, Vincristine,

Completed
  • Refractory Acute Lymphoblastic Leukemia
  • Relapsed Acute Lymphoblastic Leukemia
  • Miami, Florida
    University of Miami
Oct 19, 2022

Vitiligo Trial in Nice (Ruxolitinib Topical, Placebo)

Not yet recruiting
  • Vitiligo
  • Ruxolitinib Topical
  • Placebo
  • Nice, Alpes-maritimes, France
    CHU de Nice - Hôpital de l'Archet
May 22, 2023